Integrated management of dry eye–depression comorbidity: mechanistic insights and temporal therapeutic strategies - Takeaways - MDSpire

Integrated management of dry eye–depression comorbidity: mechanistic insights and temporal therapeutic strategies

  • By

  • Te-du Yang

  • Chuan-long Wu

  • Xiao-juan Li

  • Shao-rong Hu

  • Jing Zang

  • June 2, 2026

  • 0 min

Share

  • 1

    Dry eye disease (DED) and depressive disorder frequently co-occur, significantly impacting patient quality of life and healthcare systems.

  • 2

    Current care models are fragmented and inadequate, lacking integrated management frameworks for the comorbidity of DED and depression.

  • 3

    Shared biological pathways, including neurogenic inflammation, link DED and depression, necessitating a holistic treatment approach.

  • 4

    The article advocates for a paradigm shift towards integrated, patient-centered care that addresses both ocular and psychological symptoms.

  • 5

    Understanding the timing of interventions is crucial for effective management of the bidirectional relationship between DED and depression.

Original Source(s)

Integrated management of dry eye–depression comorbidity: mechanistic insights and temporal therapeutic strategies

  • by Te-du Yang, Chuan-long Wu, Xiao-juan Li, Shao-rong Hu, Jing Zang

  • June 2, 2026

Related Content

Language-based detection of depression with machine learning: systematic review and meta-analysis

Equal Pay in Ophthalmology? Not Yet

A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks

Beyond IOP: The Mood Effects of CAIs

Evidence from large US dataset suggests topical carbonic Anhydrase Inhibitors may increase depression risk in glaucoma patients

  • March 12, 2026

  • 5 min